V
Vanta Bioscience
VANTABIO Share Price
Healthcare17.20
as on 13 Mar 2026 at 14:50
BSE
Market Cap
₹12 Cr
PE Ratio
-1.00
ROCE
-14.43%
VANTABIO Fundamentals
Company Valuation
Market Cap (₹ Cr.)
12
PE Ratio
-1.00
PB Ratio
0.91
Dividend Yield
-
ROE
-351.27%
ROCE
-14.43%
Book Value (₹)
20.28
Face Value (₹)
10.00
Share Holding Pattern
| Held By | Mar 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|
| Promoters | 69.36% | 69.36% | 69.36% | 72.81% | 72.81% |
| Domestic Institutional Investors (DII) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Foreign Institutional Investors (FII) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Investors | 25.97% | 26.55% | 26.35% | 23.39% | 23.66% |
| Government | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Promoters
Domestic Institutional Investors (DII)
Foreign Institutional Investors (FII)
Public Investors
Government
VANTABIO Investment Returns
Short Term
1 Week
1 Month
3 Months
6 Months
9 Months
Long Term
1 Year
2 Years
3 Years
4 Years
5 Years
- In Short Term
- In Long term
1 Week
1 Month
3 Months
6 Months
9 Months
Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.
Stock & Sector Information
Sector
Healthcare
Sub Sector
Healthcare Technology
Company Classification
SME
BSE Scrip Code
540729
NSE Scrip Name
VANTABIO
ISIN
INE695X01011



